- Events at the IDM | Institute Of Infectious Disease and . . .
Events at the IDM Events and seminars hosted and or organised by the IDM are indexed on the respective IDM calendars Kindly note certain events may require an R S V P or registration Please reach out to the contact person listed in the event details should you have any queries about the event
- Full Members | Institute Of Infectious Disease and . . .
Full membership to the IDM is for researchers who are fully committed to conducting their research in the IDM, preferably accommodated in the IDM complex, for 5-year terms, which are renewable
- SARS-CoV-2 spike T cell responses induced upon vaccination . . .
The SARS-CoV-2 Omicron variant has multiple Spike (S) protein mutations that contribute to escape from the neutralizing antibody responses, and reducing vaccine protection from infection The extent to which other components of the adaptive response such as T cells may still target Omicron and contribute to protection from severe outcomes is unknown We assessed the ability of T cells to react
- A third dose of inactivated vaccine augments the potency . . .
Emergence of variants of concern (VOC) with altered antigenic structures and waning humoral immunity to SARS-CoV-2 are harbingers of a long pandemic Administration of a third dose of an inactivated virus vaccine can boost the immune response Here, we have dissected the immunogenic profiles of antibodies from 3-dose vaccinees, 2-dose vaccinees and convalescents
- Structural Rigidification of N-Aryl-pyrroles into Indoles . . .
A series of indolyl-3-methyleneamines incorporating lipophilic side chains were designed through a structural rigidification approach and synthesized for investigation as new chemical entities against Mycobacterium tuberculosis (Mtb) The screening led to the identification of a 6-chloroindole analogue 7j bearing an N-octyl chain and a cycloheptyl moiety, which displayed potent in vitro
- Coronavirus: studies show T cells fight Omicron even when . . .
The study from the University of Cape Town’s Institute of Infectious Disease and Molecular Medicine looked at patients who had recovered from Covid-19 or been vaccinated with shots from Pfizer
- T cells come to the rescue as studies show they fight . . .
The study from the University of Cape Town’s Institute of Infectious Disease and Molecular Medicine looked at patients who had recovered from Covid or been vaccinated with shots from Pfizer and partner BioNTech or Johnson Johnson They found that 70-80% of the T cell responses they assessed held up against Omicron
- UCT Staff
Institute of Infectious Disease and Molecular Medicine: Health Sciences: 21 January 2022: Proposal Development Specialist View advert | View job description: Research Office: 21 January 2022: IT Manager View advert: DTHF: 21 January 2022: Learning Design Partner View advert | View job description: Business Development Unit: Graduate School of